Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Loma Linda, California 92354


We hypothesize that tranexamic acid administration will be associated with 25% improvement in the volume of blood loss and red blood cell (RBC) administration, with no increase or a decrease in perioperative complications


Inclusion Criteria: 1. Is the subject 18 years of age or older? 2. Is the subject scheduled for primary cardiac surgery utilizing cardiopulmonary bypass(CPB)? 3. Is the subject more than 30 kg ( 66 lbs)? 4. Does subject understand English? Exclusion Criteria: 1. Does the subject have existing coagulation defects (INR > 1.5, platelets < 100 ? 2. Does the subject have renal failure (defined as BUN/Cr ratio 20:1 ? 3. Does the subject have severe liver disease (AST & ALT> 3x normal) ? 4. Is the subject having emergency cardiac surgery, complex aortic surgery, combination valve/CABG surgeries, or redo cardiac surgery? 5. Is the subject having any procedure where CPB is not anticipated? 6. Is the patient weight greater than 150 kg?



Primary Contact:

Principal Investigator
Jason Gatling, MD
Loma Linda University Medical Center

Backup Contact:


Location Contact:

Loma Linda, California 92354
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.